{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:02:48Z","timestamp":1794373368476,"version":"4.9.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"DOI":"10.1186\/s12859-025-06263-5","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:58:14Z","timestamp":1761040694000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Big data dimensionality reduction-based supervised machine learning algorithms for NASH diagnosis"],"prefix":"10.1186","volume":"26","author":[{"given":"Onder","family":"Tutsoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huseyin Ali","family":"Ozturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilmi Erdem","family":"Sumbul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"issue":"11","key":"6263_CR1","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/nrgastro.2013.149","volume":"10","author":"A Wree","year":"2013","unstructured":"Wree A, et al. From NAFLD to NASH to cirrhosis\u2014new insights into disease mechanisms. Nat Rev Gastroenterol Hepatol. 2013;10(11):627\u201336.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"6263_CR2","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/apt.17158","volume":"56","author":"L Henry","year":"2022","unstructured":"Henry L, et al. The epidemiologic burden of non-alcoholic fatty liver disease across the world. Aliment Pharmacol Ther. 2022;56(6):942\u201356.","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"6263_CR3","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/S2468-1253(23)00159-0","volume":"8","author":"H Tilg","year":"2023","unstructured":"Tilg H, et al. NASH drug treatment development: challenges and lessons. Lancet Gastroenterol Hepatol. 2023;8(10):943\u201354.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"6263_CR4","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41591-023-02242-6","volume":"29","author":"SA Harrison","year":"2023","unstructured":"Harrison SA, et al. Challenges and opportunities in NASH drug development. Nat Med. 2023;29(3):562\u201373.","journal-title":"Nat Med"},{"issue":"1","key":"6263_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2022.100873","volume":"28","author":"D Contreras","year":"2023","unstructured":"Contreras D, et al. Diagnostic accuracy of blood biomarkers and non-invasive scores for the diagnosis of NAFLD and NASH: systematic review and meta-analysis. Ann Hepatol. 2023;28(1):100873.","journal-title":"Ann Hepatol"},{"issue":"3","key":"6263_CR6","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s42000-022-00377-8","volume":"21","author":"S Kechagias","year":"2022","unstructured":"Kechagias S, et al. Non-invasive diagnosis and staging of non-alcoholic fatty liver disease. Hormones (Athens). 2022;21(3):349\u201368.","journal-title":"Hormones (Athens)"},{"issue":"6","key":"6263_CR7","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.jhep.2022.04.002","volume":"76","author":"V Ratziu","year":"2022","unstructured":"Ratziu V, Francque S, Sanyal AJJoh. Breakthroughs in therapies for NASH and remaining challenges. J Hepatol. 2022;76(6):1263\u201378.","journal-title":"J Hepatol"},{"issue":"2","key":"6263_CR8","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s12072-022-10300-3","volume":"16","author":"Y-S Lee","year":"2022","unstructured":"Lee Y-S, et al. MRE-based NASH score for diagnosis of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease. Hepatol Int. 2022;16(2):316\u201324.","journal-title":"Hepatol Int"},{"issue":"6","key":"6263_CR9","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1002\/hep4.1689","volume":"5","author":"AS Barritt","year":"2021","unstructured":"Barritt AS, et al. Patient determinants for histologic diagnosis of NAFLD in the real world: a TARGET-NASH study. Hepatol Commun. 2021;5(6):938\u201346.","journal-title":"Hepatol Commun"},{"key":"6263_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11306-020-01756-1","volume":"17","author":"M Masarone","year":"2021","unstructured":"Masarone M, et al. Untargeted metabolomics as a diagnostic tool in NAFLD: discrimination of steatosis, steatohepatitis and cirrhosis. Metabolomics. 2021;17:1\u201313.","journal-title":"Metabolomics"},{"issue":"1","key":"6263_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2020-001174","volume":"8","author":"KI Zheng","year":"2020","unstructured":"Zheng KI, et al. Combined and sequential non-invasive approach to diagnosing non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease and persistently normal alanine aminotransferase levels. BMJ Open Diabetes Res Care. 2020;8(1):e001174.","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"1","key":"6263_CR12","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/HEP.0000000000000364","volume":"78","author":"J Lee","year":"2023","unstructured":"Lee J, et al. Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH: a development and validation study. Hepatology. 2023;78(1):258\u201371.","journal-title":"Hepatology"},{"issue":"6","key":"6263_CR13","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1093\/jamia\/ocab003","volume":"28","author":"M Docherty","year":"2021","unstructured":"Docherty M, et al. Development of a novel machine learning model to predict presence of nonalcoholic steatohepatitis. J Am Med Inform Assoc. 2021;28(6):1235\u201341.","journal-title":"J Am Med Inform Assoc"},{"key":"6263_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmjhci-2021-100510","author":"O Yasar","year":"2022","unstructured":"Yasar O, et al. Machine learning using longitudinal prescription and medical claims for the detection of non-alcoholic steatohepatitis (NASH). BMJ Health Care Inform. 2022. https:\/\/doi.org\/10.1136\/bmjhci-2021-100510.","journal-title":"BMJ Health Care Inform"},{"issue":"1","key":"6263_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-51741-0","volume":"14","author":"AR Naderi Yaghouti","year":"2024","unstructured":"Naderi Yaghouti AR, Zamanian H, Shalbaf AJSR. Machine learning approaches for early detection of non-alcoholic steatohepatitis based on clinical and blood parameters. Sci Rep. 2024;14(1):2442.","journal-title":"Sci Rep"},{"key":"6263_CR16","doi-asserted-by":"crossref","unstructured":"Dhanka S, et al. Advancements in hybrid machine learning models for biomedical disease classification using integration of hyperparameter-tuning and feature selection methodologies: a comprehensive review 2025:1\u201336.","DOI":"10.1007\/s11831-025-10309-5"},{"issue":"6","key":"6263_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0325900","volume":"20","author":"A Kumar","year":"2025","unstructured":"Kumar A, et al. Comprehensive framework for thyroid disorder diagnosis: integrating advanced feature selection, genetic algorithms, and machine learning for enhanced accuracy and other performance matrices. PLoS ONE. 2025;20(6):e0325900.","journal-title":"PLoS ONE"},{"issue":"3","key":"6263_CR18","doi-asserted-by":"publisher","first-page":"035233","DOI":"10.1088\/2631-8695\/ad76f9","volume":"6","author":"A Kumar","year":"2024","unstructured":"Kumar A, Singh J, Khan AAJERE. A comprehensive machine learning framework with particle swarm optimization for improved polycystic ovary syndrome (PCOS) diagnosis. Eng Res Express. 2024;6(3):035233.","journal-title":"Eng Res Express"},{"key":"6263_CR19","doi-asserted-by":"crossref","unstructured":"Zamanian H, Shalbaf A. Engineering, estimation of non-alcoholic steatohepatitis (NASH) disease using clinical information based on the optimal combination of intelligent algorithms for feature selection and classification 2024;27(8):964\u2013979.","DOI":"10.1080\/10255842.2023.2217978"},{"key":"6263_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fbinf.2025.1522401","volume":"5","author":"S Ghosh","year":"2025","unstructured":"Ghosh S, Mandal SD, Thakur SJFiB. Biomarker-driven drug repurposing for NAFLD-associated hepatocellular carcinoma using machine learning integrated ensemble feature selection. Front Bioinform. 2025;5:1522401.","journal-title":"Front Bioinform"},{"key":"6263_CR21","unstructured":"National Institue of Health (NIH). https:\/\/www.nih.gov\/ 2024."},{"issue":"7","key":"6263_CR22","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.2337\/dc22-2048","volume":"46","author":"L Castera","year":"2023","unstructured":"Castera L, et al. High prevalence of NASH and advanced fibrosis in type 2 diabetes: a prospective study of 330 outpatients undergoing liver biopsies for elevated ALT, using a low threshold. Diabetes Care. 2023;46(7):1354\u201362.","journal-title":"Diabetes Care"},{"issue":"1","key":"6263_CR23","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/MPG.0b013e318291fefe","volume":"57","author":"K Puri","year":"2013","unstructured":"Puri K, et al. Serum bilirubin level is inversely associated with nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr. 2013;57(1):114\u20138.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"6263_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-023-01318-1","volume":"23","author":"H Fu","year":"2023","unstructured":"Fu H, et al. Association between hypertension and the prevalence of liver steatosis and fibrosis. BMC Endocr Disord. 2023;23(1):85.","journal-title":"BMC Endocr Disord"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-025-06263-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12859-025-06263-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-025-06263-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:01:55Z","timestamp":1761084115000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-025-06263-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6263"],"URL":"https:\/\/doi.org\/10.1186\/s12859-025-06263-5","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"18 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"256"}}